N-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)acetamide, 98%, 5g

3-Iodo-1H-pyrrolo[2,3-b]pyridine, 97.0%, 10g

6-Bromo-7-methylpyrazolo[1,5-a]pyridine, 97.0%, 1g

(2R)-1-(11bR)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,2,3,4-tetrahydro-2-methylquinoline, 97%, 100mg

1H,1H,2H,2H-Tridecafluoro-n-octyl Acrylate (stabilized with HQ + MEHQ)>98.0%(GC)25g

1-Chloro-2,4-dimethyl-5-nitrobenzene, 95.0%, 5g

2-Bromo-1-(2,6-dichlorophenyl)ethanone, 95.0%, 5g

1-(2-Cyanophenyl)piperidine-4-carboxylic acid, 95.0%, 5g

3-FLUOROCYCLOPENTAN-1-AMINE HYDROCHLORIDE, 95%, 250mg

3-Amino-2-hydroxypyridine, 99.0%, 1g

5-Amino-1-(3-methoxy-phenyl)-3-methyl-1H-pyrazole-4-carbonitrile, 95.0%, 1g

6-Bromo-4-methylpyridin-3-amine, 97.0%, 10g

1-Benzyl 2-methyl (2s,4s)-4-hydroxypiperidine-1,2-dicarboxylate, 98%, 250mg